AMR

3,5-DIAMINO-N-(AMINOIMINOMETHYL)-6-CHLOROPYRAZINECARBOXAMIDE

Created: 2000-07-18
Last modified:  2020-06-05

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count23
Chiral Atom Count0
Bond Count23
Aromatic Bond Count6
2D diagram of AMR
Toggle HydrogenToggle Labels

Chemical Component Summary

Name3,5-DIAMINO-N-(AMINOIMINOMETHYL)-6-CHLOROPYRAZINECARBOXAMIDE
SynonymsAMILORIDE
Systematic Name (OpenEye OEToolkits)3,5-diamino-N-carbamimidoyl-6-chloro-pyrazine-2-carboxamide
FormulaC6 H8 Cl N7 O
Molecular Weight229.627
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04Clc1nc(C(=O)NC(=[N@H])N)c(nc1N)N
SMILESCACTVS3.341NC(=N)NC(=O)c1nc(Cl)c(N)nc1N
SMILESOpenEye OEToolkits1.5.0c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=N)N
Canonical SMILESCACTVS3.341 NC(=N)NC(=O)c1nc(Cl)c(N)nc1N
Canonical SMILESOpenEye OEToolkits1.5.0 c1(c(nc(c(n1)Cl)N)N)C(=O)NC(=N)N
InChIInChI1.03 InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)
InChIKeyInChI1.03 XSDQTOBWRPYKKA-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB00594 
NameAmiloride
Groups approved
DescriptionA pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705)
Synonyms
  • Amipramidin
  • N-amidino-3,5-diamino-6-chloropyrazinecarboxamide
  • Amilorida
  • 3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
  • Amilorid
Brand Names
  • Amiloride Hydrochloride Tablets, USP
  • Amiloride Hydrocloride
  • Moduret
  • Mylan-amilazide
  • Midamor Tablets 5mg
IndicationFor use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.
Categories
  • Acid Sensing Ion Channel Blockers
  • Agents causing hyperkalemia
  • Cardiovascular Agents
  • Decreased Renal K+ Excretion
  • Diuretics
ATC-CodeC03DB01
CAS number2609-46-3

Drug Targets

NameTarget SequencePharmacological ActionActions
Amiloride-sensitive sodium channel subunit alphaMEGNKLEEQDSSPPQSTPGLMKGNKREEQGLGPEPAAPQQPTAEEEALIE...unknowninhibitor
Amiloride-sensitive sodium channel subunit betaMHVKKYLLKGLHRLQKGPGYTYKELLVWYCDNTNTHGPKRIICEGPKKKA...unknowninhibitor
Amiloride-sensitive sodium channel subunit gammaMAPGEKIKAKIKKNLPVTGPQAPTIKELMRWYCLNTNTHGCRRIVVSRGR...unknowninhibitor
Amiloride-sensitive sodium channel subunit deltaMAEHRSMDGRMEAATRGGSHLQAAAQTPPRPGPPSAPPPPPKEGHQEGLV...unknowninhibitor
Amiloride-sensitive amine oxidase [copper-containing]MPALGWAVAAILMLQTAMAEPSPGTLPRKAGVFSDLSNQELKAVHSFLWS...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL945
PubChem 137319713, 16231
ChEMBL CHEMBL945
ChEBI CHEBI:2639
CCDC/CSD XEFTUA, TIJMII, TUPJEU
COD 2012278, 2226238